ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database
News Aug 15, 2017
ACD/Labs is delighted to announce a collaboration with researchers at the Núcleo de Bioensaios Biossíntese e Ecofisiologia de Produtos Naturais (NuBBE). ACD/NMR Predictors were chosen by the group to populate their Brazilian biodiversity natural products database (NuBBEDB) with predicted nuclear magnetic resonance (NMR) data.
ACD/Labs technology enabled automatic prediction of 1H and 13C spectra, using their industry-leading NMR prediction tools, for compounds already in the database and for new compounds as they are added in future. The NMR data is provided as searchable information—peak lists and coupling constants. “We chose the ACD/Labs software because it has reliable, robust algorithms and accurate predictions,” says Vanderlan da Silva Bolzani, project coordinator.
“We are happy to support academic research with our technology,” says Dimitris Argyropoulos, NMR business manager at ACD/Labs. “Academic research is fueling and supporting commercial R&D more and more these days. With the majority of prescribed medicines still derived from natural compounds, and Brazil considered to have the greatest biodiversity of any country on the planet, the NuBBEDB will be a valuable resource for scientists investigating compounds for new medicines. I hope the NMR data our software is providing will help natural products researchers to more quickly identify and characterize novel chemical scaffolds in their search for the therapies of tomorrow.”
Unchained Labs Unveils LEA 9 Software Making Workflows EasyNews
Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, released its LEA 9 software, making Freeslate and Junior automation systems way more accessible.READ MORE
Human Microbiome Project: Millions of New Genes IdentifiedNews
A new study of the human microbiome, the trillions of microbial organisms that live on and within our bodies, has uncovered millions of previously unknown genes.READ MORE
$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification PlatformNews
ChromaTan Corporation, a provider of continuous and single-use chromatography solutions for the biotechnology industry, has been awarded a $2.5M contract from the Food and Drug Administration (FDA).READ MORE